Dr. Sabari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Chief Residency, Internal Medicine, 2014 - 2015- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2011 - 2014
Rutgers Robert Wood Johnson Medical SchoolClass of 2011
Certifications & Licensure
NY State Medical License 2013 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 825 citationsImmune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryJulien Mazieres, Alexander Drilon, Amélie Lusque, Laurent Mhanna, Alexis B. Cortot
Annals of Oncology. 2019-08-01 - 50 citationsAdagrasib in Advanced Solid Tumors Harboring aMutation.Tanios S Bekaii-Saab, Rona Yaeger, Alexander I Spira, Meredith S Pelster, Joshua K Sabari
Journal of Clinical Oncology. 2023-09-01 - 25 citationsComparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas.Lawrence Hsu Lin, Douglas H R Allison, Yang Feng, George Jour, Kyung En Park
Modern Pathology. 2021-08-06
Journal Articles
- PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung CancersG J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
- Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung CancerJoshua Sabari, MD, Clinical Cancer Research
- Case Report Next-Generation Sequencing Based Detection of Germline and Somatic Alterations in a Patient with Four Metachronous Primary TumorsJoshua K Sabari, Gulisa Turashvili, Vicky Makker, Darragh F Halpenny, ScienceDirect
Press Mentions
A Potential GSK Game Changer and an MRNA Cancer Vaccine: Highlights from the 2022 ASCO ConferenceJune 10th, 2022
OncLive® Presents Its Latest State of the Science Summit™ on Advanced Non-Small Cell Lung CancerDecember 5th, 2018- Impact of COVID-19 on Oncology Drug ShortagesJune 2nd, 2023
- Join now to see all
Professional Memberships
- Member
Other Languages
- Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
